Repligen (RGEN) Share-based Compensation (2010 - 2026)
Repligen (RGEN) posted quarterly Share-based Compensation of $76.9 million for Q2 2026, up 818.21% year-over-year from $8.4 million in Q2 2025, and down 7.57% quarter-over-quarter from $83.2 million in Q1 2026.
Repligen (RGEN) Share-based Compensation (2010 - 2026) Analysis & Trends
Repligen (RGEN) has reported Share-based Compensation for 17 consecutive years, with $76.9 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Share-based Compensation rose 818.21% year-over-year to $76.9 million; the TTM figure through Jun 2026 stood at $76.9 million (up 70.65% YoY), while the FY2025 annual figure was $63.7 million, up 12.74% from the prior year.
- Share-based Compensation declined to $76.9 million in Q2 2026 per RGEN's latest filing, from $83.2 million in the prior quarter.
- Across five years, Share-based Compensation topped out at $83.2 million in Q1 2026 and bottomed at $3.4 million in Q4 2022.
- Historically, Share-based Compensation has averaged $17.3 million across 5 years, with a median of $8.2 million in 2025.
- Annual changes were most pronounced in 2022 — Share-based Compensation plunged 94.72% — and 2026, when it surged 1043.96%.
- Repligen's Share-based Compensation stood at $3.4 million in 2022, then surged by 88.98% to $6.5 million in 2023, then slipped by 1.64% to $6.4 million in 2024, then rose by 25.55% to $8.0 million in 2025, then soared by 863.18% to $76.9 million in 2026.
- Business Quant data shows RGEN's Share-based Compensation at $76.9 million in Q2 2026, $83.2 million in Q1 2026, and $8.0 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 67.10 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 55.00 Mn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | 42.00 Mn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 27.46 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 29.00 Mn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 10.90 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 38.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | - |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 33.00 Mn |
| 10 | Repligen | 10.25 Bn | 9.24 Bn | 110.04 Mn | 76.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 76.90 Mn |
| Jun 30, 2026 | 76.90 Mn |
| Mar 31, 2026 | 83.20 Mn |
| Mar 31, 2026 | 83.20 Mn |
| Dec 31, 2025 | 7.98 Mn |
| Dec 31, 2025 | 7.98 Mn |
| Sep 30, 2025 | 8.97 Mn |
| Sep 30, 2025 | 8.97 Mn |
| Jun 30, 2025 | 8.38 Mn |
| Jun 30, 2025 | 8.38 Mn |
| Mar 31, 2025 | 7.27 Mn |
| Mar 31, 2025 | 7.27 Mn |
| Dec 31, 2024 | 6.36 Mn |
| Dec 31, 2024 | 6.36 Mn |
| Sep 30, 2024 | 23.06 Mn |
| Sep 30, 2024 | 23.06 Mn |
| Jun 30, 2024 | 9.88 Mn |
| Jun 30, 2024 | 9.88 Mn |
| Mar 31, 2024 | 23.09 Mn |
| Mar 31, 2024 | 23.09 Mn |